- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr Laura Long Says Pathways Are Part of a Bigger Care Delivery Transformation
Historically, people talk about pathways as if they are an answer, but they are really just one component to cancer care delivery, said Laura Long, MD, MPH, president at TheLongView, PC.
Historically, people talk about pathways as if they are an answer, but they are really just one component to cancer care delivery, said Laura Long, MD, MPH, president at TheLongView, PC, and editorial board member for The American Journal of Pharmacy Benefits.
"What [pathways] can do is help reduce variation and help improve the delivery of evidence-based care, but you need to have the rest of the package," she said.
Payment still needs to be aligned with outcomes and the care delivery model needs to become more patient-centered, Dr Long added.
Quality of Life: The Pending Outcome in Idiopathic Pulmonary Fibrosis
February 6th 2026Because evidence gaps in idiopathic pulmonary fibrosis research hinder demonstration of antifibrotic therapies’ impact on patient quality of life (QOL), integrating validated health-related QOL measures into trials is urgently needed.
Read More
